Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUE-AHF: Ularitide (Urodilatin) in Acute Decompensated Heart Failure
2010-024249-59Phase 3Completed
- Sponsor
- Cardiorentis AG
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Ularitide arm with Placebo arm (2 arms). Primary endpoint: Co-primary endpoints. Started Aug 2012; status: completed.
02
Drugs
ularitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2010-024249-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024249-59.